Phosphorylation of tau regulates its axonal transport by controlling its binding to kinesin

被引:131
作者
Cuchillo-Ibanez, Inmaculada [1 ]
Seereeram, Anjan [1 ]
Byers, Helen L.
Leung, Kit-Yi
Ward, Malcolm A.
Anderton, Brian H. [1 ]
Hanger, Diane P. [1 ]
机构
[1] Kings Coll London, Inst Psychiat, MRC Ctr Neurodegenerat Res, London SE5 8AF, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
GSK-3; mass spectrometry; lithium;
D O I
10.1096/fj.08-109181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Defective axonal transport has been proposed as an underlying mechanism that may give rise to neurodegeneration. We investigated the effect of phosphorylation on the axonal transport of tau, a neuronal protein that stabilizes microtubules and is hyperphosphorylated and mislocalized in Alzheimer's disease. We report here that specific inhibition of glycogen synthase kinase-3 (GSK-3) reduces tau phosphorylation and significantly decreases the overall rate of axonal transport of tau in rat cortical neurons. Tau mutants, with serine/threonine targets of GSK-3 mutated to glutamate to mimic a permanent state of phosphorylation, were transported at a significantly increased rate compared to wild-type tau. Conversely, tau mutants, in which alanine replaced serine/threonine to mimic permanent dephosphorylation, were transported at a decreased rate compared to wild-type tau. We also found that tau interacts with the light chain of kinesin-1 and that this is dependent on the phosphorylation state of tau. Tau phosphorylation by GSK-3 increased binding, and dephosphorylated tau exhibited a reduced association with kinesin-1. We conclude that GSK-3 phosphorylation of tau modulates its axonal transport by regulating binding to kinesin-1. Hyperphosphorylated tau in Alzheimer's disease appearing first in distal portions of axons may result from aberrant axonal transport of phosphorylated tau reported here.
引用
收藏
页码:3186 / 3195
页数:10
相关论文
共 59 条
[1]   Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments [J].
Ackerley, S ;
Thornhill, P ;
Grierson, AJ ;
Brownlees, J ;
Anderton, BH ;
Leigh, PN ;
Shaw, CE ;
Miller, CCJ .
JOURNAL OF CELL BIOLOGY, 2003, 161 (03) :489-495
[2]   Glycogen synthase kinase-3: Properties, functions, and regulation [J].
Ali, A ;
Hoeflich, KP ;
Woodgett, JR .
CHEMICAL REVIEWS, 2001, 101 (08) :2527-2540
[3]  
Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73
[4]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[5]   Disruption of cellular transport: a common cause of neurodegeneration? [J].
Crosby, AH .
LANCET NEUROLOGY, 2003, 2 (05) :311-316
[6]  
Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.t01-1-00251.x
[7]   GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and β-catenin stabilisation without elevation of glycogen synthase activity [J].
Culbert, AA ;
Brown, MJ ;
Frame, S ;
Hagen, T ;
Cross, DAE ;
Bax, B ;
Reith, AD .
FEBS LETTERS, 2001, 507 (03) :288-294
[8]   Specificity and mechanism of action of some commonly used protein kinase inhibitors [J].
Davies, SP ;
Reddy, H ;
Caivano, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2000, 351 (351) :95-105
[9]   Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase [J].
Derkinderen, P ;
Scales, TME ;
Hanger, DP ;
Leung, KY ;
Byers, HL ;
Ward, MA ;
Lenz, C ;
Price, C ;
Bird, IN ;
Perera, T ;
Kellie, S ;
Williamson, R ;
Noble, W ;
Van Etten, RA ;
Leroy, K ;
Brion, JP ;
Reynolds, CH ;
Anderton, BH .
JOURNAL OF NEUROSCIENCE, 2005, 25 (28) :6584-6593
[10]   Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: Neurofilaments attenuate tau-mediated neurite instability [J].
Dubey, Maya ;
Chaudhury, Pulkit ;
Kabiru, Hilda ;
Shea, Thomas B. .
CELL MOTILITY AND THE CYTOSKELETON, 2008, 65 (02) :89-99